Citation Impact
Citing Papers
The clinical symptoms of Parkinson's disease
2016 Standout
Central pattern generators for locomotion control in animals and robots: A review
2008 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Parkinson disease
2017 Standout
The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease
2002
Deep Brain Stimulation for Parkinson’s Disease
2008
Parkinson's disease
2021 Standout
Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies
2018
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Parkinson's disease: The quintessential neuropsychiatric disorder
2011
Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment
2005
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision
2010 Standout
Parkinson’s Disease as a Disconnection Syndrome
2010
Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
2018
Postural instability in idiopathic Parkinson's disease: the role of medication and unilateral pallidotomy
2002
Factors associated with depression in Parkinson's disease
2011
Dopaminergic modulation of motor network dynamics in Parkinson's disease
2015
Parkinson's disease: clinical features and diagnosis
2008 Standout
Updates on the prevalence of body dysmorphic disorder: A population-based survey
2010 Standout
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
2012
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
The pathophysiological basis of sensory disturbances in Parkinson's disease
2009
Disabling repetitive behaviors in Parkinson's disease
2003
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study
2007
Neuroanatomical and Neurochemical Substrates of Timing
2010 Standout
Non‐motor symptoms in Parkinson’s disease
2008
The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
2018
Dynamic Sensorimotor Interactions in Locomotion
2005
Parkinson's disease
2009 Standout
Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease
2008
Virtual Sensory Feedback for Gait Improvement in Neurological Patients
2013
Gait characteristics and falls in Parkinson's disease: A systematic review and meta-analysis
2018
Canadian guideline for Parkinson disease
2019 Standout
Epidemiology of Parkinson’s disease
2017 Standout
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
2018
Parkinson's disease in the Western Pacific Region
2019
Parkinson's disease
2015 Standout
Pathophysiological distortions in time perception and timed performance
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease
2005
Effects of external rhythmical cueing on gait in patients with Parkinson's disease: a systematic review
2005
Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease
2001
Pain in Parkinson's disease
2010
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
Use of human intravenous immunoglobulin in lower motor neuron syndromes
1999
Gender and non motor fluctuations in Parkinson's disease: A prospective study
2016
Effects of rhythmic sensory stimulation (auditory, visual) on gait in Parkinson’s disease patients
2008
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
2008
Elusive roles for reactive astrocytes in neurodegenerative diseases
2015
Non-motor features of Parkinson disease
2017 Standout
Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
2006
An Update on Monoclonal Gammopathy and Neuropathy
2011
Gait variability: methods, modeling and meaning
2005 Standout
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Levodopa/carbidopa/entacapone in Parkinson’s disease
2009
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease
2008
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease
2004
Parkinson Disease and Exercise
2013
Postural deformities in Parkinson's disease
2011
Dopamine dysregulation syndrome in Parkinson's disease
2004
Effects of deep brain stimulation on prehensile movements in PD patients are less pronounced when external timing cues are provided
2003
Amyotrophic Lateral Sclerosis
2001 Standout
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
2012
Clinical approach to nonmotor sensory fluctuations in Parkinson's disease
2011
De novo design of a homo-trimeric amantadine-binding protein
2019 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Nonmotor symptoms of Parkinson’s disease
2006
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
2015
Dopamine Dysregulation Syndrome
2009
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
2008
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Fatigue in levodopa-naive subjects with Parkinson disease
2008
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Is fatigue an independent and persistent symptom in patients with Parkinson disease?
2004
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment
2000
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Constipation: an emerging risk factor for Parkinson's disease?
2016
Nonmotor Symptoms in Nursing Home Residents with Parkinson's Disease: Prevalence and Effect on Quality of Life
2013
Case Studies in the Advancement of Parkinson's Disease
2008
Visual dysfunction in Parkinson disease without dementia
2005
Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan
2017
Nonmotor fluctuations in Parkinson disease
2013
Works of J.-P. Azulay being referenced
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
2005
Visual control of locomotion in Parkinson's disease
1999
Les fluctuations non motrices de la maladie de Parkinson
2007
Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease
2007
Lewis-Sumner syndrome and multifocal motor neuropathy
2004
Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study
2016
Impaired vertical postural control and proprioceptive integration deficits in Parkinson’s disease
2007
A sensitive flow cytometry method for anti-GM1 antibodies detection
2002
Postural disorders in Parkinson’s disease
2008
Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson?s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study
2004
Le syndrome de l’homme raide : formes cliniques, traitement et profil évolutif
2006
Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy
2009
Nonmotor fluctuations in Parkinson’s disease
2002
Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3)
2017
Increased Visual Dependence in Parkinson's Disease
2002
Long term follow up of multifocal motor neuropathy with conduction block under treatment.
1997